The impact of minimally invasive surgical therapy for Benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis - PubMed
11 hours ago
- #Minimally Invasive Surgical Treatments
- #Benign Prostatic Hyperplasia
- #Sexual Function
- Minimally invasive surgical treatments (MISTs) for Benign Prostatic Hyperplasia (BPH) aim to alleviate lower urinary tract symptoms (LUTS) while preserving sexual function.
- A systematic review and meta-analysis evaluated sexual function outcomes post-MISTs, including erectile and ejaculatory function.
- The study analyzed 77 studies with 11,477 patients, focusing on various MISTs like Rezum, Urolift, PAE, iTIND, Optilume, and TPLA.
- Results showed significant improvement in International Index of Erectile Function (IIEF) scores after Rezum and Urolift treatments.
- Urolift improved both function and bother scores in the Male Sexual Health Questionnaire (MSHQ), while Rezum only improved bother scores.
- Other MISTs like PAE, iTIND, Optilume, and TPLA did not significantly impact erectile or ejaculatory function.
- MISTs are promising for BPH patients concerned about maintaining or improving sexual function post-treatment.